Citeline Podcasts

Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.

On this week’s podcast we talk about a recent survey that shows how medical device makers and their sales reps have been impacted by surgical restrictions brought on by the pandemic. Also: a spotlight on Ellume Health’s COVID-19 Home Test.

Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.

In this week’s podcast: LivaNova sells its heart valve business to a private equity firm, an expert panel discusses the challenges of addressing so-called “metabesity,” and Dexcom explains its plans to double its revenue over the next few years.

Listen to the podcast via the player below:

Medtech Insight article addressing topics discussed in this episode:

LivaNova Sells Surgical Heart Valve Business To Gyrus Capital For $73M

Conquering Metabesity: Expert Panel Discusses Roadmap To Find Solutions

Exec Chat: Dexcom CEO Kevin Sayer Talks About Access, Growth, Resiliency During Pandemic

Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.

On this week’s podcast: A change made by the US FDA to its MedWatch program that asks adverse event reporters whether a third party serviced a malfunctioning medical device went unnoticed by many in industry for nearly a year. We explain why, and tell how the servicer question will be helpful for manufacturers and the agency.

Medtech Insight article addressing topics discussed in this episode:

• Recent eMDR Change By FDA Asks Adverse Event Reporters About Third-Party Servicers

https://medtech.pharmaintelligence.informa.com/MT142951/Recent-eMDR-Change-By-FDA-Asks-Adverse-Event-Reporters-About-Third-Party-Servicers

Pink Sheet reporters and editors look at the UK MHRA’s surprising approval of the Pfizer/BioNTech coronavirus vaccine, as well as the US reaction, and discuss President-elect Joe Biden’s potential US FDA commissioner nominees.

ISTAND Pilot Program with FDA's Steve Berman by Citeline

Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.

Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.